AstraZeneca PLC
(NASDAQ:AZN)
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
top performing AZN trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent AstraZeneca trades made by congress members.
Daniel GoldmanHouse (D-NY) | $100K - $250K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
Alan S. LowenthalHouse (D-CA) | $1K - $15K | stock | Sale | Dec 14, 2021 | Dec 01, 2021 | House |